David M. Faleck

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study”.

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003277

N/A

0DataRank · unranked

118 citations

David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang +13 more

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.024

N/A

0DataRank · unranked

109 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9092

N/A

0DataRank · unranked

2 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series

The Oncologist(2022)10.1093/oncolo/oyac019

N/A

0DataRank · unranked

10 citations

Michael A. Postow, David M. Faleck, Jessica Harris

375: CONCURRENT IMMUNE CHECKPOINT INHIBITION AND SELECTIVE IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH IMMUNE-RELATED ENTEROCOLITIS

Gastroenterology(2022)10.1016/s0016-5085(22)60201-4

N/A

0DataRank · unranked

1 citations

Fangwen Zou, Sienna Durbin, Barbara E. Dutra, Donna Leet, Hamzah Abu‐Sbeih +8 more

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Nature Communications(2023)10.1038/s41467-022-35592-9

N/A

0DataRank · unranked

52 citations

Henry Walch, Jaclyn F. Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck +23 more

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0498

N/A

0DataRank · unranked

39 citations

Nicholas R. Waters, Natalie Smith, Anqi Dai, John Slingerland, Nathan Aleynick +24 more

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007195

N/A

0DataRank · unranked

28 citations

Fangwen Zou, Sienna Durbin, Barbara E. Dutra, Hamzah Abu‐Sbeih, Anusha Shirwaikar Thomas +11 more

Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad150

N/A

0DataRank · unranked

21 citations

I‐Hsin Lin, James Flory, Hans Gerdes, Michael A. Postow, David M. Faleck +1 more

Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer

Journal of Cancer(2023)10.7150/jca.84261

N/A

0DataRank · unranked

9 citations

Malek Shatila, Antony Mathew, Antonio Pizuorno Machado, Austin R. Thomas, Hao Chi Zhang +9 more

Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes

The Oncologist(2023)10.1093/oncolo/oyad226

N/A

0DataRank · unranked

7 citations

Deepika Satish, Ngolela Esther Babady, Mini Kamboj, Michael A. Postow, Monika Laszkowska +2 more

Accelerating the Evolution of Immune-Related Enterocolitis Management

Journal of Clinical Oncology(2023)10.1200/jco.22.02914

N/A

0DataRank · unranked

11 citations

Michael Dougan, Monique Tello, Joseph E. Grossman, Alan C. Moss, Michael A. Postow +1 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

medRxiv(2023)10.1101/2023.05.15.23289680

N/A

0DataRank · unranked

4 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +23 more

Serum cytokines and autoantibodies to GM-CSF and immune-related colitis in ipilimumab-treated patients with cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12080

N/A

0DataRank · unranked

0 citations

Diane M. Del Valle, Kevin Tuballes, Vanessa Barcessat, Stephanie King, Hsin Huang +11 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

Nature Communications(2024)10.1038/s41467-023-44512-4

N/A

0DataRank · unranked

33 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +28 more

Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis

The Journal of Experimental Medicine(2024)10.1084/jem.20232079

N/A

0DataRank · unranked

12 citations

Diane M. Del Valle, Graham J. Britton, K Mead, Urvija Rajpal, Alice Chen-Liaw +14 more

Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry

Clinical Gastroenterology and Hepatology(2024)10.1016/j.cgh.2024.05.006

N/A

0DataRank · unranked

14 citations

Yue Jiang, Cristina Villagra, Jean‐Frédéric Colombel, Keith Sultan, Dana J. Lukin +13 more